Mirae Asset Global Etfs Holdings Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 92,824 shares of RARE stock, worth $4.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
92,824Holding current value
$4.71 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
293Shares Held
88.2MCall Options Held
535KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$496 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$284 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$272 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$231 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$165 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.55B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...